HLAProtein.com was developed by Pure Protein, L.L.C and aims to provide researchers worldwide with best in class HLA protein reagents and testing services. Pure Protein was founded on the proprietary technologies of William Hildebrand, Ph.D. and is a portfolio company of life sciences technology management firm Emergent Technologies, Inc.
Pure Protein’s Scientific Team is comprised of leading experts with extensive knowledge in HLA research. With over 100 years of cumulative experience, the Company has developed a portfolio of proprietary technologies and methodologies that aim to support researchers across the world in HLA immunology. From soluble HLA manufacturing and diagnostics development to peptide binding and epitope discovery, our team looks forward to working with our customers and collaborators.
Pure Protein is a biotechnology company focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system. After over 20 years of developing these technologies, Pure Protein launched the HLAProtein.com website in 2020 to supply academic and commercial research groups with best in class, proprietary HLA protein reagents and testing services. HLAProtein.com now provides the world’s largest selection of single specificity, naturally folded, glycosylated soluble HLA proteins and HLA peptide binding services.
Thomas Harlan, CEO, Emergent Technologies, Inc. and Dr. William Hildebrand, Chief Scientist, Pure Protein, LLC
Pure Protein, independently and in concert with worldwide collaborators, aims to bring novel therapies, diagnostics, and research tools to clinicians, vaccine designers and researchers across an expansive variety of fields including transplantation, oncology, autoimmunity and infectious diseases.
MEET THE TEAM
Dr. Rico Buchli
Biochemistry, Molecular Biology & Immunology
Director of Research
Vice President of Products and Services